Factor V Leiden Is Not Common in Children with Portal Vein Thrombosis

C A Seixas; G Hessel; C C Ribeiro; V R Arruda; J M Annichino-Bizzacchi

doi:10.1055/s-0038-1655949

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1997; 77(02): 258-261
DOI: 10.1055/s-0038-1655949

Original Article

Schattauer GmbH Stuttgart

Factor V Leiden Is Not Common in Children with Portal Vein Thrombosis

Autoren

C A Seixas

¹The Department of Pediatrics, São Francisco University, Bragança Paulista, SP, Brazil
G Hessel

²The Department of Pediatrics, State University of Campinas, UNICAMP, Campinas, SP, Brazil
C C Ribeiro

³Hematology-Hemotherapy Center, State University of Campinas, UNICAMP, Campinas, SP, Brazil
V R Arruda

³Hematology-Hemotherapy Center, State University of Campinas, UNICAMP, Campinas, SP, Brazil
J M Annichino-Bizzacchi

³Hematology-Hemotherapy Center, State University of Campinas, UNICAMP, Campinas, SP, Brazil

Abstract

als PDF herunterladen

Summary

Portal vein thrombosis (PVT) is a rare condition affecting both children and adults, and occurs in association with a wide variety of clinical situations. On the other hand, the development of PVT in patients under these situations indicates that other contributing factors could be envolved. Recently a missense mutation in the factor V gene (1691G→A), known as factor V Leiden, has been identified and results in abnormal factor V product, resistant to proteolytic inactivation by activated protein C and thus predisposes to thrombosis. This study was carried out to verify if children with PVT have an increase in frequency of factor V Leiden. Allele-specific restriction analysis and single strand conformational polymorphism (SSCP) were used to test for factor V Leiden in 20 children with PVT and 64 normal children. None of the PVT children were heterozygous or homozygous for the factor V Leiden, and one control child was heterozygous. This study demonstrates that factor V Leiden is not common in children with PVT, and is not a prerequisite for this thrombotic event.

PDF (264 kb)

Referenzen

References
1 Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odièvre M, Alagille D. Portal obstruction in children. I. Clinical investigation and hemorrhage risk. JPed 1983; 103: 696-702
2 Thompson EN, Sherlock S. The aetiology of portal vein thrombosis with particular reference to the role of infection and exchange transfusion. QJ Med 1964; 132: 465-479
3 Orloff MJ, Orloff MS, Rambotti M. Treatment of bleeding esophagogastric varices due to extrahepatic portal hypertension: Results of portal-systemic shunts during 35 years. J Pediatr Surg 1994; 29: 142-151
4 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Nat Acad Sci 1993; 90: 1004-1008
5 Koster T, Rosendaal FR, deRonde H, Briët E, Vandenbroucke J, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
6 Griffin JH, Evatt B, Wideman C, Fernández JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993
7 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
8 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, deRonde H, van der VeldenPA, Reitsma PH. Mutation in blood coagulation factor V associated with resistence to activated protein C. Nature 1994; 369: 64-67
9 Majerus PW. Bad blood by mutation. Nature 1994; 369: 14-15
10 Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-1508
11 Arruda VR, Annichino-Bizzacchi JM, Costa FF, Reitsma PH. Factor V Leiden (FVQ506) is common in Brazilian population. Am J Hematol 1995; 39: 242-243
12 Arruda VR, vonZuben PM, Soares MCP, Menezes RC, Annichino-Bizzacchi JM, Costa FF. Low incidence of Arg→Gln mutation in the factor gene among Amazonian Indians and Brazilian black population. Thromb Haemost 1996; 75: 860-861
13 Kodaira H, Ishida F, Ito T, Ichikava N, Shimodaira S, Takamiya O, Furihata K, Kiyosawa K, Kitano K. Arg 506 Gin factor V mutation is uncommon in Eastern Asian population. Blood 1995; 86: 917 a abstr 3658.
14 Dilley A, Austin H, Cupertino M, Hooper C, Wenger N, Evatt B. Risk factors for deep vein thrombosis in an African-American population. Blood 1995; 86: 87 a abstr 337
15 Petäjä J, Lundstrӧm U, Sairanen H, Marttinen E, Griffin JH. Activated protein resistence and central venous thrombosis after cardiac surgery in 2487 children. Blood 1995; 86: 922 a
16 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. An Biol Chem 1966; 15: 45-52
17 Sambrook J, Fritsch EF, Maniatis T. Molecular C loning A Laboratory Manual (ed2). Cold Spring Harbor New York Cold Spring Harbor Laboratory. 1989
18 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higushi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487
19 Arruda VR, vonZuben PM, Annichino-Bizzacchi JM, Costa FF. Factor V Leiden (FVQ506) by non-radioactive single strand conformation polymorphism (SSCP). Sangre. 1996 in press.